D-138

Garlic, Viscum Album Fruiting Top, Olea Europaea Flower Bud, Prunus Dulcis Flower, Pyridoxine Hydrochloride, Cyanocobalamin, Folic Acid, Potassium Iodide, And Cholesterol


Dna Labs, Inc.
Human Otc Drug
NDC 58264-0146
D-138 also known as Garlic, Viscum Album Fruiting Top, Olea Europaea Flower Bud, Prunus Dulcis Flower, Pyridoxine Hydrochloride, Cyanocobalamin, Folic Acid, Potassium Iodide, And Cholesterol is a human otc drug labeled by 'Dna Labs, Inc.'. National Drug Code (NDC) number for D-138 is 58264-0146. This drug is available in dosage form of Solution. The names of the active, medicinal ingredients in D-138 drug includes Cholesterol - 6 [hp_X]/mL Cyanocobalamin - 6 [hp_X]/mL Folic Acid - 4 [hp_X]/mL Garlic - 1 [hp_X]/mL Olea Europaea Flower Bud - 1 [hp_X]/mL Potassium Iodide - 3 [hp_X]/mL Prunus Dulcis Flower - 1 [hp_X]/mL Pyridoxine Hydrochloride - 3 [hp_X]/mL Viscum Album Fruiting Top - 2 [hp_X]/mL . The currest status of D-138 drug is Active.

Drug Information:

Drug NDC: 58264-0146
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: D-138
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Garlic, Viscum Album Fruiting Top, Olea Europaea Flower Bud, Prunus Dulcis Flower, Pyridoxine Hydrochloride, Cyanocobalamin, Folic Acid, Potassium Iodide, And Cholesterol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Dna Labs, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Solution
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CHOLESTEROL - 6 [hp_X]/mL
CYANOCOBALAMIN - 6 [hp_X]/mL
FOLIC ACID - 4 [hp_X]/mL
GARLIC - 1 [hp_X]/mL
OLEA EUROPAEA FLOWER BUD - 1 [hp_X]/mL
POTASSIUM IODIDE - 3 [hp_X]/mL
PRUNUS DULCIS FLOWER - 1 [hp_X]/mL
PYRIDOXINE HYDROCHLORIDE - 3 [hp_X]/mL
VISCUM ALBUM FRUITING TOP - 2 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jan, 1990
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 21 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:DNA Labs, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:M0022794
N0000175951
N0000185371
N0000175629
N0000184306
M0000728
M0006342
M0016962
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:97C5T2UQ7J
P6YC3EG204
935E97BOY8
V1V998DC17
L2178V0V81
1C4QK22F9J
1DBN9N0FWJ
68Y4CF58BV
BK9092J5MP
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Vitamin B12 [EPC]
Non-Standardized Food Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Vitamin B 12 [CS]
Allergens [CS]
Dietary Proteins [CS]
Plant Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Analogs/Derivatives [Chemical/Ingredient]
Cell-mediated Immunity [PE]
Dietary Proteins [CS]
Increased Histamine Release [PE]
Non-Standardized Food Allergenic Extract [EPC]
Plant Proteins [CS]
Vitamin B 12 [CS]
Vitamin B 6 [Chemical/Ingredient]
Vitamin B12 [EPC]
Vitamin B6 Analog [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
58264-0146-129.57 mL in 1 BOTTLE, GLASS (58264-0146-1)01 Jan, 1990N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Blood fat metabolism.

Product Elements:

D-138 garlic, viscum album fruiting top, olea europaea flower bud, prunus dulcis flower, pyridoxine hydrochloride, cyanocobalamin, folic acid, potassium iodide, and cholesterol alcohol water garlic garlic viscum album fruiting top viscum album fruiting top olea europaea flower bud olea europaea flower bud prunus dulcis flower prunus dulcis flower pyridoxine hydrochloride pyridoxine cyanocobalamin cyanocobalamin folic acid folic acid potassium iodide iodide ion cholesterol cholesterol

Indications and Usage:

Indications blood fat metabolism.

Warnings:

Warnings use only if cap seal is unbroken. if pregnant or breastfeeding, ask a healthcare professional before use. keep this and all medication out of the reach of children.

Dosage and Administration:

Suggested dosage one dropper under tongue two times daily. acute symptoms ½ dropper under tongue every 30 minutes for two hours.

Package Label Principal Display Panel:

Principal display panel - 1 fl. oz. bottle label dynamic nutritional associates, inc. d 138 homeopathic stress formula 1 fl. oz. principal display panel - 1 fl. oz. bottle label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.